A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Researchers shed light on the "dark matter" of the gut, revealing a species of fungus that could potentially help counter ...

Metabolic dysfunction-associated fatty liver disease is now recognised as the most common chronic liver disease globally, ...

Obesity causes temporary disruptions, but not permanent structural changes, in the liver’s molecular network that regulates ...

A new study reveals that a single gene plays a big role in how the liver stores energy, a process that's critical for overall health and for managing diseases like type 2 diabetes. The research ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A groundbreaking study from the University of Oklahoma reveals that the hormone FGF21 can reverse fatty liver disease by ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

Women who experience menopause before the age of 50—and especially before the age of 45—are more likely to develop fatty ...

A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...